- Homepage
- What’s New
- Registration
- Your Portfolio
- Markets
- Economy
- Knowledge
- Events
- About Us
Results Update
This company has an executable order book of USD 296 million in the next 12 months. The earnings visibility in the next 12 months is expected to propel the stock to higher levels cRead More
14 Jan 2015
Infosys has maintained FY 15 guidance of 7% to 9% revenue growth in USD terms which is not very encouraging. We would expect other majors to show double digit revenue growth for FYRead More
09 Jan 2015
ING Vysya has given 152% returns in our portfolios since recommendation. We are replacing ING Vysya Bank with its acquirer Kotak Mahindra Bank as we believe Kotak will gain value fRead More
25 Nov 2014
INY Vysya Bank stock has given 152% returns from our original recommended price of Rs.320. We are placing this stock on watch list. ING Vysya Bank has a weight of 5% and 6% in our Read More
20 Nov 2014
This stock has posted better than expected financial results with net profit growth of 31% to Rs.40.23 billion in Q2FY15 compared to corresponding quarter of the previous year. GroRead More
15 Nov 2014
This company reported a 72.62% decrease in the consolidated net profit to Rs.1248 million from Rs.4560 million on a year on year basis and a decrease of 35.48% from Rs.1935 millionRead More
14 Nov 2014
The company reported a 166.59% increase in the consolidated net profit to Rs.8502 million from Rs.3189 million on a year on year basis and an increase of 1746.68% from Rs.460 milliRead More
14 Nov 2014
The company reported a 50.15% decline in the consolidated net profit to Rs.4642 million from Rs.9311 million on a year on year basis and a decrease of 61.83% from Rs.12,163 millionRead More
14 Nov 2014
This company reported a 29% rise in the consolidated net profit to Rs.1196 million from Rs.928 million on a year on year basis and an increase 4.89% from Rs.1140 million on a sequeRead More
13 Nov 2014
This company reported sales of Rs.21,080 million in Q2FY15 that were up by 20.68% compared to the last year same quarter. Major sales growth has come from the US formulation busineRead More
11 Nov 2014
